Michelle Nannini

3.6k citations

35 papers · 1.6k indexed · h-index 19

Molecular Biology top 10%
Cellular and Molecular Neuroscience top 5%
Oncology top 10%
Behavioral Neuroscience top 2%
Cancer Research top 10%

Co-authors: Clyde W. Hodge M. Foster Olive Heather N. Koenig Kristin K. Mehmert Stephen P. Kelley Alison M. Bratt Rosana Camarini Deepak Sampath
Topics: PI3K/AKT/mTOR signaling in cancer (9 papers)Neurotransmitter Receptor Influence on Behavior (5 papers)Stress Responses and Cortisol (4 papers)
Cited by: Behavioral Neuroscience Cellular and Molecular Neuroscience Biological Psychiatry
Journals: Proceedings of the National Academy of Sciences Journal of Neuroscience Blood
Partner nations: United States France Switzerland

In The Last Decade

Michelle Nannini

34 papers receiving 1.5k citations

Peers

Countries citing papers authored by Michelle Nannini

Since Specialization

Citations

This map shows the geographic impact of Michelle Nannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Nannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Nannini more than expected).

Fields of papers citing papers by Michelle Nannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Nannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Nannini. The network helps show where Michelle Nannini may publish in the future.

Co-authorship network of co-authors of Michelle Nannini

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Nannini. A scholar is included among the top collaborators of Michelle Nannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Nannini. Michelle Nannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human 2024 ·Xenobiotica ·Laurent Salphati,Jodie Pang,Emile G. Plise,Jonathan Cheong,(unknown),(unknown),(unknown),Allan Jaochico,(unknown),Ning Liu,Michelle Nannini,Deepak Sampath,Kyung Song,(unknown),Steven T. Staben	5
2	Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State 2018 ·Cell Metabolism ·Anneleen Daemen,Bonnie Liu,(unknown),Mandy Kwong,Min Gao,Rebecca Hong,Michelle Nannini,David Peterson,Bianca M. Liederer,(unknown),Dewakar Sangaraju,Allan Jaochico,Xiaofeng Zhao,Wendy Sandoval,Thomas Hunsaker,Ron Firestein,(unknown),Deepak Sampath,Marie Evangelista,Georgia Hatzivassiliou	56
3	Abstract 156: Preclinical characterization of GDC-0077, a specific PI3K alpha inhibitor in early clinical development 2017 ·Cancer Research ·Kyle A. Edgar,Emily J. Hanan,Steven T. Staben,Stephen Schmidt,Rebecca Hong,Kyung Song,Amy Young,(unknown),Alfonso Arrazate,(unknown),Marcia Belvin,Michelle Nannini,Lori S. Friedman,Deepak Sampath	11
4	Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer 2016 ·Clinical Cancer Research ·Wei Yang,(unknown),Lloye M. Dillon,Kevin Shee,(unknown),(unknown),Laurent Salphati,Jodie Pang,Xiaolin Zhang,Michelle Nannini,Eugene Demidenko,Darcy Bates,Lionel D. Lewis,Jonathan D. Marotti,Alan Eastman,Todd W. Miller	27
5	PI3 kinase/mTOR inhibition increases sensitivity of ER positive breast cancers to CDK4/6 inhibition by blocking cell cycle re-entry driven by cyclinD1 and inducing apoptosis 2015 ·Annals of Oncology ·María Teresa Herrera-Abreu,Uzma Asghar,(unknown),Alex Pearson,Michelle Nannini,(unknown),(unknown),Mitch Dowsett,Lesley‐Ann Martin,Nicholas C. Turner	6
6	Modeling Targeted Inhibition of MEK and PI3 Kinase in Human Pancreatic Cancer 2014 ·Molecular Cancer Therapeutics ·Melissa R. Junttila,Vidusha Devasthali,Jason Chia‐Hsien Cheng,Joseph Castillo,Ciara Metcalfe,(unknown),(unknown),Emily Chan,Hani Bou-Reslan,Tim C. Cao,William F. Forrest,Michelle Nannini,Dorothy French,Richard A.D. Carano,Mark Merchant,Klaus P. Hoeflich,Mallika Singh	43
7	MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma 2014 ·Molecular Cancer Therapeutics ·Jyoti Asundi,Jennifer A. Lacap,Suzanna Clark,Michelle Nannini,Leslie Roth,Paul Polakis	20
8	Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity 2014 ·Nanoscale Research Letters ·Po‐Chang Chiang,Stephen E. Gould,Michelle Nannini,Ann Qin,Yuzhong Deng,Alfonso Arrazate,(unknown),Yingqing Ran,Harvey Wong	12
9	Bcl-2/Bcl-xL Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models 2013 ·Molecular Cancer Therapeutics ·Nguyen Tan,(unknown),Michelle Nannini,Rebecca Hong,Leslie B. Lee,S. Russ Price,Karen Williams,Pascal Savy,Peng Yue,Deepak Sampath,Jeffrey Settleman,Wayne J. Fairbrother,Lisa D. Belmont	61
10	Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models 2013 ·Neoplasia ·Thomas O’Brien,Jason Oeh,Yang Xiao,Xiaorong Liang,Alexander Vanderbilt,Ann Qin,Lulu Yang,Leslie B. Lee,Justin Q. Ly,Ely Cosino,Jennifer A. Lacap,Annie Ogasawara,Simon P. Williams,Michelle Nannini,Bianca M. Liederer,Peter K. Jackson,Peter S. Dragovich,Deepak Sampath	47
11	Combination of the glycoengineered Type II CD20 antibody obinutuzumab (GA101) and The novel Bcl-2 selective Inhibitor GDC-0199 Results in superior In Vitro and In Vivo Anti-tumor activity in models Of B-Cell Malignancies 2013 ·Blood ·Deepak Sampath,Sylvia Herter,Frank Herting,Ellen Ingalla,Michelle Nannini,Marina Bacac,Wayne J. Fairbrother,Christian Klein	4
12	Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells 2011 ·Proceedings of the National Academy of Sciences ·Weiwei Chen,Tracy Tang,Jeff Eastham-Anderson,Debra Dunlap,Bruno Alicke,Michelle Nannini,Stephen E. Gould,Robert L. Yauch,Zora Modrušan,Kelly DuPree,Walter C. Darbonne,Gregory D. Plowman,Frédéric J. de Sauvage,Christopher A. Callahan	93
13	Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models 2010 ·Nature Biotechnology ·Mallika Singh,(unknown),Rafael Molina,(unknown),(unknown),Vidusha Devasthali,Jennifer D. Thompson,Jason Cheng,Hani Bou Reslan,Calvin Ho,(unknown),Chingwei V. Lee,Michelle Nannini,Germaine Fuh,Richard A.D. Carano,Hartmut Koeppen,Ron Yu,William F. Forrest,Gregory D. Plowman,Leisa Johnson	175
14	Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake 2002 ·Pharmacology Biochemistry and Behavior ·M. Foster Olive,Heather N. Koenig,Michelle Nannini,Clyde W. Hodge	190
15	Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release 2002 ·European Journal of Pharmacology ·M. Foster Olive,Michelle Nannini,(unknown),Heather N. Koenig,Clyde W. Hodge	64
16	Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration 2001 ·Peptides ·Stephen P. Kelley,Michelle Nannini,Alison M. Bratt,Clyde W. Hodge	81
17	Allopregnanolone and Pentobarbital Infused Into the Nucleus Accumbens Substitute for the Discriminative Stimulus Effects of Ethanol 2001 ·Alcoholism Clinical and Experimental Research ·Clyde W. Hodge,Michelle Nannini,M. Foster Olive,Stephen P. Kelley,Kristin K. Mehmert	13
18	Reduced ethanol withdrawal severity and altered withdrawal-induced c-fos expression in various brain regions of mice lacking protein kinase C-epsilon 2001 ·Neuroscience ·M. Foster Olive,Kristin K. Mehmert,Michelle Nannini,Rosana Camarini,Robert O. Messing,Clyde W. Hodge	42
19	The discriminative stimulus properties of self-administered ethanol are mediated by GABA A and NMDA receptors in rats 2001 ·Psychopharmacology ·Clyde W. Hodge,(unknown),Alison M. Bratt,Rosana Camarini,(unknown),Steven P. Kelley,Kristin K. Mehmert,Michelle Nannini,M. Foster Olive	30
20	Allopregnanolone and Pentobarbital Infused Into the Nucleus Accumbens Substitute for the Discriminative Stimulus Effects of Ethanol 2001 ·Alcoholism Clinical and Experimental Research ·Clyde W. Hodge,Michelle Nannini,M. Foster Olive,Stephen P. Kelley,Kristin K. Mehmert	33

About Michelle Nannini

Michelle Nannini is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Geriatrics and Gerontology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Stress Responses and Cortisol (4 papers). The work is most often cited by research in Behavioral Neuroscience (226 citations), Cellular and Molecular Neuroscience (620 citations) and Biological Psychiatry (53 citations). Michelle Nannini has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Clyde W. Hodge, M. Foster Olive, Heather N. Koenig, Kristin K. Mehmert, Stephen P. Kelley, Alison M. Bratt, Rosana Camarini, Deepak Sampath, Gregory D. Plowman and Vidusha Devasthali. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact